biospecimen_aliquot__bcr_aliquot_barcode	tcga-ew-a1oz-01a-11d-a142-09
biospecimen_aliquot__bcr_aliquot_uuid	a73152be-2293-403d-940b-74ac05810808
biospecimen_aliquot__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_aliquot__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474078
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-04-06
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a142
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.98
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ew-a1oz-01a-11d
biospecimen_analyte__bcr_analyte_uuid	98e1b3d3-4f11-446d-b3a0-0de88d07ba27
biospecimen_analyte__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_analyte__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ew-a1oz
biospecimen_diagnostic_slides__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	9639bb06-ff02-475f-a89d-773be12721cc
biospecimen_normal_control__bcr_patient_barcode	tcga-ew-a1oz
biospecimen_normal_control__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_portion__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_portion__bcr_portion_barcode	tcga-ew-a1oz-01a-11
biospecimen_portion__bcr_portion_uuid	e7a89d76-0564-42f2-9550-bd6e60a11fcb
biospecimen_portion__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_portion__date_of_creation	2011-03-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ew-a1oz-01a-11d
biospecimen_protocol__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_protocol__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_sample__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_sample__bcr_sample_uuid	ac0612f6-3d84-44d5-a224-6cbe65531505
biospecimen_sample__days_to_collection	928
biospecimen_sample__initial_weight	210
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ew-a1oz.42de8e2c-395d-4e9b-b7bc-6a0b2f9bd7ce.pdf
biospecimen_sample__pathology_report_uuid	42de8e2c-395d-4e9b-b7bc-6a0b2f9bd7ce
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	ec87ecc1-dbdd-478f-aea6-a982f92222e8
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ew-a1oz-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
biospecimen_slide__bcr_sample_barcode	tcga-ew-a1oz-01a
biospecimen_slide__bcr_slide_barcode	tcga-ew-a1oz-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	5b179149-f5d2-4b79-8988-5c2fc2268cdc
biospecimen_slide__image_file_name	tcga-ew-a1oz-01a-01-tsa.5b179149-f5d2-4b79-8988-5c2fc2268cdc.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	10
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	10
biospecimen_slide__percent_stromal_cells	26
biospecimen_slide__percent_tumor_cells	64
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ew-a1oz
biospecimen_tumor_sample__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
clinical_drug__bcr_drug_barcode	tcga-ew-a1oz-d30292
clinical_drug__bcr_drug_uuid	4d0a2fad-1e7f-4624-b437-150ef0d4e686
clinical_drug__bcr_patient_barcode	tcga-ew-a1oz
clinical_drug__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
clinical_drug__form_completion_date	2012-3-8
clinical_drug__pharma_adjuvant_cycles_count	3
clinical_drug__pharmaceutical_therapy_drug_name	docetaxel
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	186
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	144
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	142
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	426
clinical_follow_up__bcr_followup_barcode	tcga-ew-a1oz-f29098
clinical_follow_up__bcr_followup_uuid	652d6657-335d-47dd-b917-8793b786c736
clinical_follow_up__bcr_patient_barcode	tcga-ew-a1oz
clinical_follow_up__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-8
clinical_follow_up__last_contact_days_to	1229
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	56
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-ew-a1oz
clinical_patient__bcr_patient_uuid	8f912a40-3251-4e1f-ae65-1f93d71f9881
clinical_patient__birth_days_to	-20664
clinical_patient__cent17_copy_number	2
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__first_surgical_procedure_other	total mastectomy
clinical_patient__form_completion_date	2011-5-11
clinical_patient__gender	female
clinical_patient__her2_and_cent17_cells_count	40
clinical_patient__her2_cent17_ratio	2.2
clinical_patient__her2_fish_status	positive
clinical_patient__her2_ihc_percent_positive	20-29%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	941
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	4
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a1oz
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	ew
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1OZ-01A-11D-A142-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1OZ-01A-11D-A142-09.bed.meta
manually_curated__id	tcga-ew-a1oz-01a-11d-a142-09
manually_curated__md5sum	52bf848135ff49ecaa7241fc59261fc5
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	a73152be-2293-403d-940b-74ac05810808
manually_curated__tumor_tag	brca
